CI
AGIO icon

Cowen Inc’s Agios Pharmaceuticals AGIO Stock Holding History

Cowen Inc’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,950
Closed -$550K – 256
2015
Q2 		$550K Sell
4,950
-475
-9% -$51.2K 0.03% 226
2015
Q1 		$512K Sell
5,425
-8,880
-62% -$995K 0.04% 220
2014
Q4 		$1.6M Buy
+14,305
New +$1.28M 0.13% 105

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cowen Inc's AGIO Position: Q3 2015 in Review

Cowen Inc sold out of Agios Pharmaceuticals (AGIO) in Q3 2015, closing a stake of 4,950 shares — an estimated $550K sold.

Cowen Inc first reported a position in AGIO in Q4 2014 and held it in 3 quarters. The position peaked at $1.6M in Q4 2014. 151 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

  • Cowen Inc reported no remaining Agios Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Cowen Inc sold 4,950 Agios Pharmaceuticals shares in Q3 2015, an estimated $550K.
  • Cowen Inc first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Cowen Inc's Agios Pharmaceuticals position peaked at $1.6M in Q4 2014.
  • 151 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.